Nuclear medicine techniques for radio-guided surgery of hyperparathyroidism

Minerva Endocrinologica

Volumn 33, Issue 2, 2008, Pages 95-104

  Ugur O ^a   Bozkurt, M F ^a   Rubello, D ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Hyperparathyroidism, surgery; Molecular probe techniques; Radionuclide imaging; Ultrasonography

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOISOTOPE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; TRACER;

CELLULAR DISTRIBUTION; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC SURGERY; HEAD AND NECK SURGERY; HUMAN; HYPERPARATHYROIDISM; MINIMALLY INVASIVE SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; PARATHYROID SCINTISCANNING; PARATHYROIDECTOMY; PREOPERATIVE EVALUATION; REVIEW; SENSITIVITY ANALYSIS; ULTRASOUND; UNILATERAL NECK EXPLORATION; METHODOLOGY; PREOPERATIVE CARE; RADIOSURGERY; SCINTISCANNING; TREATMENT OUTCOME;

HUMANS; HYPERPARATHYROIDISM; MAGNETIC RESONANCE IMAGING; PARATHYROIDECTOMY; PREOPERATIVE CARE; RADIOACTIVE TRACERS; RADIOPHARMACEUTICALS; RADIOSURGERY; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 49849106765     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Heath H, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: Incidence, morbidity and potential economic impact in a community. N Eng J Med 1980;302:189-93.
2. Clark OH, Siperstein AE. The hypercalcemic syndrome. In: Friesen SR, Thomson NW, editors. Surgical Endocrinology Clinical Syndromes. Philadelphia, PA: Lippincott; 1990.p.311-39.
3. Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 2002;17(Suppl 2):N18-N23.
4. Mariani G, Gulec SA, Rubello D, Boni G, Puccini M, Pelizzo MR et al. Preoperative localization and radioguided parathyroid surgery. J Nucl Med 2003;44:1443-58.
5. Mandl F. Therapeutic attempt of osteitis fibrosa generalisata by excision of an epithelial-corpuscle tumors. Wien Klin Wochenschr 1925;195:1343-4.
6. Rudberg C, Akerstrom G, Palmer M. Late results of operation for primary hyperparathyroidism in 441 patients. Surgery 1986;99:643-51.
7. Gagne ER, Urena P, Leita-Silva S. Short and long term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients. J Am Soc Nephrol 1992;3:1008-17.
8. Järhult J, Nordenström J, Perbeck L. Reoperation for suspected primary hyperparathyroidism. Br J Surg 1993;80:453-6.
9. NIH Conference: diagnosis and management of asymptomatic primary hyperparathyroidism-consensus development conference statement. Consensus Development Conference, NIH. Ann Intern Med 1991;114:593-97.
10. Shaha AR, LaRosa CA, Jaffe BM. Parathyroid localization prior to primary exploration. Am J Surg 1993;166:289-93.
11. Denham DW, Norman J. Cost-effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely upon the surgeon's choice of operative procedure. J Am Coll Surg 1998;186:296-304.
12. Roth SI, Wang CA, Patts JT Jr. The team approach to primary hyperparathyroidism. Hum Pathol 1975;6:645-8.
13. Tiblin S, Bondeson AG, Bondeson L, Ljunberg O. Surgical strategy in hyperparathyroidism due to solitary adenoma. Am Surg 1984;200:776-84.
14. Duh QY, Udeen P, Clark OH. Unilateral neck exploration for primary hyperparathyroidism:Analysis of a controversy using a mathematical model. World J Surg 1992;16:654-62.
15. Miccoli P, Bendinelli C, Berti P. Video-assisted versus conventional parathyroidectomy in primary hyperparathyroidism. A prospective randomized study. Surgery 1999;126:117-22.
16. Gulec SA, Ugur O. The intellectual and scientific basis of parathyroid surgery. Turk J Med Sci 2004;34:81-4.
17. Sackett WR, Barraclough B, Reeve TS, Delbridge LW. Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimal invasive parathyroidectomy. Arch Surg 2002;137:1055-9.
18. Coakley AJ, Kettle AG, Wells CP, O'Doherty MJ, Collins RE. 99Tcm sestamibi-a new agent for parathyroid imaging. Nucl Med Commun 1989;10:791-4.
19. Taillefer R. Parathyroid tumors. In: Aktolun C, Tauxe WN, editors. Nuclear Oncology. New York: Springer-Verlag; 1999. p. 214-8.
20. Lee VS, Wilkinson RH Jr, Leight GS Jr, Coogan AC, Coleman RE. Hyperparathyroidism in high-risk surgical patients: evaluation with double-phase technetium-99m sestamibi imaging . Radiology 1995;197:627-33.
21. Hetrakul N, Civelek AC, Stagg CA, Udelsman R. In vitro accumulation of technetium-99m-sestamibi in human parathyroid mitochondria. Surgery 2001;130:1011-8.
22. Carpentier A, Jeannotte S, Verreault J, Lefebvre B, Bisson G, Mongeau CJ et al. Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content. J Nucl Med 1998;39:1441-4.
23. 99mTc-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance. Eur J Nucl Med 2001;28:209-13
24. Bhatnagar A, Vezza PR, Bryan JA, Atkins FB, Ziessman HA. Technetium-99m-sestamibi parathyroid scintigraphy: effect of P-glycoprotein, histology and tumor size on detectability. J Nucl Med 1998;39:1617-20.
25. 99mTc-sestamibi parathyroid scintigraphy. In: Freeman LM, editor. Nuclear Medicine Annual. New York: Raven Press; 1995. p. 51-79.
26. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993;53:977-84.
27. Ugur O, Bozkurt MF, Hamaloglu E, Sokmensuer C, Etikan I, Ugur Y et al. Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy. Arch Surg 2004;139:1175-9.
28. Giordano A, Rubello D, Casara D. New trends in parathyroid scintigraphy. Eur J Nucl Med 2001;28:1409-20.
29. Greenspan BS, Brown ML, Dillehay GL, McBiles M, Sandler MP, Seabold JE. Procedure guideline for parathyroid scintigraphy. Society of Nuclear Medicine. J Nucl Med 1998;39:1111-4.
30. Moka D, Eschner W, Voth E, Dietlein M, Larena-Avellaneda A, Schicha H. Iterative reconstruction: an improvement of Technetium-99m MIBI SPET for the detection of parathyroid adenomas? Eur J Nucl Med 2000;27:485-9.
31. 99mTc sestamibi scanning and intraoperative quick parathormone assay. Surgery 1997;122:1107-14
32. Chen CC, Holder LE, Scovill WA, Tehan AM, Gann DS. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase Technetium-99m-sestamibi and Technetium-99m-sestamibi SPECT. J Nucl Med 1997;38:834-9.
33. Staudenherz A, Abela C, Niederle B, Steiner E, Helbich T, Puig S et al. Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases. Eur J Nucl Med 1997;24:143-9.
34. Norman J. The technique of intraoperative nuclear mapping to facilitate minimally invasive parathyroidectomy. Cancer Control 1997;4:500-4.
35. Arverschoug AK, Bertelsen H, Vammen B. Presurgical localization of abnormal parathyroid glands using a single injection of Tc99m-MIBI: comparison of high resolution parallel hole and pinhole collimators, and interobserver and intraobserver variation. Clin Nucl Med 2002;27:244-54.
36. Seret A, Defriese M, Blocklet D. 180 degree pinhole SPET with a tilted detector and OSEM reconstruction:phantom studies and potential clinical applications. Eur J Nucl Med 2001;28:1836-41.
37. Sample WF, Mitchell SP, Bledsoe RC. Parathyroid ultrasonography. Radiology 1978;127:485-90.
38. Francis IS, Loney EL, Buscombe JR. Tc99m-sestamibi dual phase SPECT imaging: concordance with ultrasonography. Nucl Med Commun 1999;20:487-8.
39. Bozkurt MF, Ugur O, Hamaloglu E, Sayek I, Gulec SA. Optimization of the gamma probe-guided parathyroidectomy. Am Surg 2003; 69:720-5.
40. Tomasella G. Diagnostic imaging in primary hyperparathyroidism: radiological techniques :US-CAT-MR. Minerva Endocrinol 2001;26:3-12.
41. Mitchell BK, Merrel RC, Kinder BK. Localization studies in patients with hyperparathyroidism. Surg Clin North Am 1995;75:483-98.
42. Eisenberg H, Pallotta J, Sacks B, Brickman AS. Parathyroid localization, three-dimensional modeling and percutaneous ablation techniques. Endocrinol Metab Clin North Am 1989;18:659-700.
43. Koong HN, Choong LH, Soo KC. The role of preoperative localization techniques in surgery for hyperparathyroidism. Ann Acad Med Singapore 1998;27:192-5.
44. Weber AL, Randolph G, Aksoy FG. The thyroid and parathyroid glands: CT and MR imaging and correlation with pathology and clinical findings. Radiol Clin North Am 2000;38:1105-29.
45. Lee VS, Spritzer CE, Coleman RE. The complementary roles of fast spin-echo Mrimaging and double-phase Tc99m-MIBI scintigraphy for localization of hyperplastic glands. AJR Am J Roentgenol 1996;167:1555-62.
46. McDermott VG, Mendez Fernandez MJ, Meaken TJ III. Preoperative MR imaging in hyperparathyroidism. Results and factors affecting parathyroid detection. AJR Am J Roentgenol 1996;166:705-10.
47. Ubhi CS, Hardy JG, Peggs CAS. Mediastinal parathyroid adenoma: A new method of localization. Br J Surg 1984;71:859-60.
48. Norman J, Cheda H. Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery 1997;122:998-1004.
49. Casara D, Rubello D, Piotto A, Pelizzo MR. Tc99m-MIBI radioguided minimally invasive parathyroid surgery planned on the basis of a preoperative combined Tc99m-pertechnetate/Tc99m-MIBI and ultrasound imaging protocol. Eur J Nucl Med 2000;27:1300-4.
50. Rubello D, Casara D, Pelizzo MR. Symposium on parathyroid localization: optimization of peroperative procedures. Nucl Med Commun 2003;69:720-5.
51. Geatti O, Shapiro B, Orsolon P. Localization of parathyroid enlargement:experience with Tc99m-MIBI and thallium-201 scintigraphy ultrasound and computed tomography. Eur J Nucl Med 1994;21:17-23.
52. Rubello D, Saladini D, Casara D. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy: a fast and effective technique. Clin Nucl Med 2000;25:527-31.
53. Casara D, Rubello D, Pelizzo MR, Shapiro B. Clinical role of TcO4/MIBI scan, ultrasound and intraoperative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism. Eur J Nucl Med 2001;28:1351-9.
54. Rubello D, Mariani G, Pelizzo MR. Italian Study Group of Radioguided Surgery and Immunoscintigraphy. Minimally invasive radio-guided parathyroidectomy on a group of 452 primary hyperparathyroid patients: refinement of preoperative imaging and intraoperative procedure. Nuklearmedizin 2007;46:85-92.
55. Irvin GL III, Carneiro DM. Rapid parathyroid hormone assay guided exploration. Oper Tech Gen Surg 1999;1:18-27.
56. Starr FL, DeCresce R, Prinz RA. Use of intraoperative parathyroid hormone measurement does not improve success of bilateral neck exploration for hyperparathyroidism. Arch Surg 2001;136:536-42.
57. Murphy C, Norman J. The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery 1999;126:1023-9.
58. Ugur O, Kara PO, Bozkurt MF, Hamaloglu E, Tezel GG, Salanci BV et al. In vivo characterization of parathyroid lesions by use of gamma probe: Comparison with ex-vivo count method and frozen section results. Otolaryngol Head Neck Surg 2006;134:316-20.